Hideyuki Iwamoto Selected Research

Infections

7/2021

Pyogenic psoas abscess on the dorsal side, and bacterial meningitis and spinal epidural abscess on the ventral side, both of which were induced by spontaneous discitis in a patient with diabetes mellitus: A case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hideyuki Iwamoto Research Topics

Disease

9	Type 2 Diabetes Mellitus (MODY) 04/2024 - 09/2019
3	Body Weight (Weight, Body) 03/2024 - 01/2021
3	Hypothyroidism 01/2023 - 01/2022
3	Diabetes Mellitus 10/2022 - 01/2021
3	Hyperglycemia 10/2022 - 01/2022
2	Inflammation (Inflammations) 03/2024 - 03/2024
2	Atherosclerosis 03/2024 - 12/2020
2	Insulin Resistance 03/2024 - 10/2022
2	Pituitary ACTH Hypersecretion 10/2022 - 01/2022
2	Cushing Syndrome 10/2022 - 01/2022
2	Diabetes Complications 10/2022 - 01/2022
1	Fatty Liver 03/2024
1	Obesity 03/2024
1	COVID-19 03/2023
1	Hyperaldosteronism (Conn Syndrome) 01/2023
1	Chronic Thyroiditis 01/2023
1	Neoplasms (Cancer) 01/2023
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 10/2022
1	Acidosis 10/2022
1	Hypersensitivity (Allergy) 10/2022
1	Disease Progression 07/2022
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2022
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2022
1	Aortic Dissection 01/2022
1	Infections 07/2021
1	Thiamine Deficiency 01/2021
1	Edema (Dropsy) 01/2021
1	Dyslipidemias (Dyslipidemia) 12/2020
1	Hypertension (High Blood Pressure) 12/2020
1	Sarcopenia 12/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 09/2019
1	Overweight 09/2019

Drug/Important Bio-Agent (IBA)

5	Insulin (Novolin)FDA Link 04/2024 - 01/2022
3	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 01/2021
2	Blood Glucose (Blood Sugar)IBA 03/2024 - 09/2019
2	Biomarkers (Surrogate Marker)IBA 03/2024 - 12/2020
2	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2023 - 01/2022
2	Thyroid HormonesIBA 01/2023 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2023
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2023 - 01/2022
2	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2022 - 01/2022
1	cyclopropapyrroloindoleIBA 04/2024
1	C-PeptideIBA 04/2024
1	anagliptinIBA 03/2024
1	imegliminIBA 03/2024
1	ChemokinesIBA 03/2024
1	Sodium-Glucose Transporter 2 InhibitorsIBA 03/2024
1	Apolipoproteins E (ApoE)IBA 03/2024
1	Streptozocin (Streptozotocin)FDA Link 03/2024
1	InflammasomesIBA 03/2024
1	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 03/2024
1	Dipeptidyl-Peptidase IV InhibitorsIBA 03/2024
1	Hemoglobins (Hemoglobin)IBA 03/2024
1	semaglutideIBA 01/2024
1	dulaglutideIBA 01/2024
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2024
1	Immunoglobulin G (IgG)IBA 03/2023
1	AutoantibodiesIBA 01/2023
1	anti-thyroglobulinIBA 01/2023
1	AntibodiesIBA 01/2023
1	Iodide Peroxidase (Deiodinase)IBA 01/2023
1	LigandsIBA 01/2023
1	Programmed Cell Death 1 ReceptorIBA 01/2023
1	Furosemide (Lasix)FDA LinkGeneric 01/2023
1	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2022
1	Indicators and Reagents (Reagents)IBA 10/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022
1	KetonesIBA 10/2022
1	Insulin AntibodiesIBA 10/2022
1	InsulinsIBA 07/2022
1	insulin aspart drug combination insulin degludecIBA 07/2022
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 07/2022
1	insulin degludecIBA 07/2022
1	Insulin Glargine (Lantus)FDA Link 07/2022
1	Insulin SecretagoguesIBA 07/2022
1	Glucagon (Glukagon)FDA Link 01/2022
1	NAD (NADH)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2021
1	Thiamine (Aneurin)FDA Link 01/2021
1	Fursultiamin (Fursultiamine)IBA 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2020

Therapy/Procedure

5	Therapeutics 04/2024 - 01/2022
5	Glycemic Control 03/2024 - 09/2019
1	Ambulatory Care (Outpatient Care) 03/2023
1	Aftercare (After-Treatment) 01/2022